荣昌生物(09995)截至12月末尚未开始股份回购

Core Viewpoint - Rongchang Biologics (09995) has announced that as of December 31, 2025, the company has not yet initiated any share buybacks [1] Group 1 - The company plans to implement share buybacks opportunistically based on market conditions during the buyback period [1] - The company will fulfill its information disclosure obligations in a timely manner regarding the progress of the share buyback [1] - The progress of the buyback will comply with legal regulations and the company's buyback plan requirements [1]